Elsa Rousseau is a postdoctoral researcher in the department of Industrial and Applied Genomics at the IBM Almaden Research Center, where she is part of the Cellular Engineering team. She got her MS in Bioinformatics and Modeling at the engineer school INSA of Lyon, France, and her PhD in evolution and epidemiological modeling of pathogens at the University of Nice Sophia Antipolis, France.
Prior to her PhD, she spent one year as an engineer in Biostatistics and Modeling at the French Institute of Agronomic Research (INRA) in Avignon, studying aphids growth and spread, an important vector of plant viruses. She then did her PhD between the French Institute of Informatics and Automatics (Inria) in Sophia Antipolis and INRA Avignon, studying the effect of genetic drift and selection on the durability of plant resistance to viruses.
As a postdoctoral researcher at IBM, Dr Rousseau is studying the design principles of viral Defective Interfering Particles to use them as antiviral therapy. This work is part of a DARPA Center grant in collaboration with UC San Francisco, Stanford University and the University of Haifa. She is also providing help on a project of the Center for Cellular Construction, in partnership with SF State University, on the modeling of chromosome segregation during cell division.
Dr Rousseau has published several peer-reviewed articles in international journals. A complete list can be found at her Research Gate profile.